Mode
Text Size
Log in / Sign up

Exergaming improves strength and balance versus conventional therapy in healthy older adults

Exergaming improves strength and balance versus conventional therapy in healthy older adults
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider exergaming as an alternative for strength and balance in older adults, but note limited safety and absolute effect data.

This systematic review and meta-analysis evaluated the effects of exergaming (EXG) compared to conventional therapies on muscle strength and balance in healthy older people. The analysis included 25 randomized controlled trials with a total of 2078 participants (mean age 71.5 ± 5.8 years, ≥80% female). The review assessed outcomes including timed up-and-go (TUG), 8-TUG, maximal isometric handgrip strength, and 30-second chair stand tests.

For the TUG test, exergaming showed significant improvements over conventional therapies with effect sizes ranging from ES = 1.42 to 2.56 based on console type and games, ES = 2.07 to 2.77 based on training dosage, and ES = 2.91 for training frequency of ≥3 sessions per week (all p < 0.05). The 30-second chair stand test also showed significant improvements favoring exergaming with effect sizes of ES = 1.42 to 2.49 for training dosage (p < 0.05). A meta-regression for the chair stand test found minutes per session predicted relapse (R = 0.43, p = 0.02).

Safety and tolerability data were not reported in the provided information. The review used PRISMA, TESTEX, Rob 2, and GRADE tools to assess methodological quality and certainty of evidence. Key limitations include the reporting of only relative effect sizes without absolute numbers, lack of safety data, and insufficient detail about the specific conventional therapies used as comparators. Fear of falling outcomes were not reported.

For clinical practice, this meta-analysis suggests exergaming may be an effective alternative to conventional therapies for improving physical function in healthy older adults. However, clinicians should interpret these findings cautiously given the lack of absolute improvement data and safety information. The large effect sizes indicate potential benefit, but implementation decisions should consider individual patient factors and available resources.

Study Details

Study typeMeta analysis
Sample sizen = 2,078
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
This systematic review with meta-analysis aimed to analyze the effects of exergaming (EXG) versus conventional therapies on muscle strength, balance, and fear of falling in healthy older people. A systematic literature search was conducted in six generic databases (PubMed, Medline, CINAHL Complete, Scopus, Cochrane Library, and Web of Science) with no start date restrictions until May 2025. The PRISMA, TESTEX, Rob 2 and GRADE tools were used to assess the methodological quality and certainty of evidence. The protocol was registered in PROSPERO (code: CRD420251037541). From 3224 records, 25 randomized controlled trials with 2078 participants (≥80% female) with a mean age of 71.5 ± 5.8 years were included. Seven overall and 10 subgroup meta-analysis revealed significant improvements (p < 0.05) in favor of EXG in the timed up-and-go (TUG), 8-TUG, maximal isometric handgrip strength (MIHS) and 30-s chair stand tests. However, in the subgroup analyses of the TUG test, significant improvements (p < 0.05) were reported in favor of EXGs according to the type of console and games with very long effects (ES = 1.42-2.56) and training dosage (ES = 2.07-2.77), with improvements in only the training frequency ≥ 3 sessions per week (ES = 2.91). For the 30-s chair stand test, there were significant improvements (p < 0.05) in favor of EXG according to training dosage with very large effects (ES = 1.42-2.49). For meta-regression, only minutes per session in a 30-s chair stand test were presented as predictors of relapse in this test (R = 0.43; p = 0.02). In conclusion, EXG is an effective alternative for improving muscle strength and balance performance in healthy older people.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.